Tower View Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.8K Buy
1,240
+19
+2% +$506 0.02% 105
2025
Q4
$30.4K Buy
1,221
+20
+2% +$504 0.02% 97
2025
Q3
$30.6K Buy
1,201
+21
+2% +$518 0.02% 96
2025
Q2
$28.6K Buy
1,180
+20
+2% +$466 0.01% 110
2025
Q1
$29.4K Buy
1,160
+18
+2% +$471 0.02% 92
2024
Q4
$30.3K Buy
1,142
+19
+2% +$515 0.02% 95
2024
Q3
$32.5K Buy
1,123
+16
+1% +$467 0.02% 93
2024
Q2
$31K Buy
1,107
+17
+2% +$468 0.02% 93
2024
Q1
$30.3K Buy
1,090
+17
+2% +$472 0.02% 95
2023
Q4
$31K Sell
1,073
-843
-44% -$25.5K 0.02% 93
2023
Q3
$64K Buy
1,916
+870
+83% +$30.8K 0.04% 71
2023
Q2
$38K Buy
1,046
+11
+1% +$428 0.03% 83
2023
Q1
$42K Buy
1,035
+10
+1% +$432 0.03% 85
2022
Q4
$53K Buy
1,025
+8
+0.8% +$384 0.04% 80
2022
Q3
$45K Buy
1,017
+9
+0.9% +$437 0.03% 82
2022
Q2
$53K Buy
1,008
+8
+0.8% +$408 0.04% 79
2022
Q1
$52K Hold
1,000
0.03% 101
2021
Q4
$59K Hold
1,000
0.03% 101
2021
Q3
$43K Buy
+1,000
New +$44.3K 0.02% 107
2018
Q4
Sell
-1,476
Closed -$62K 154
2018
Q3
$62K Hold
1,476
0.05% 85
2018
Q2
$51K Hold
1,476
0.05% 86
2018
Q1
$50K Sell
1,476
-58
-4% -$1.99K 0.05% 87
2017
Q4
$53K Buy
+1,534
New +$52.3K 0.05% 89

Other funds holding PFE

Tower View Wealth Management's PFE Position: Q1 2026 in Review

Tower View Wealth Management increased its Pfizer (PFE) stake by 1.6% in Q1 2026, buying an estimated $506 and bringing the position to 1,240 shares worth $34.8K. The position accounts for 0.02% of the portfolio, ranked #105.

Tower View Wealth Management first reported a position in PFE in Q4 2017 and has held it in 23 quarters since. The position peaked at $64K in Q3 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Tower View Wealth Management held 1,240 shares of Pfizer worth $34.8K as of Q1 2026.
  • Tower View Wealth Management bought 19 Pfizer shares in Q1 2026, an estimated $506.
  • Pfizer made up 0.02% of Tower View Wealth Management's portfolio in Q1 2026, its #105 holding.
  • Tower View Wealth Management first reported a position in Pfizer in Q4 2017 and has held it in 23 quarters since.
  • Tower View Wealth Management's Pfizer position peaked at $64K in Q3 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tower View Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.